Haier invests in Yumeiren Group to carry out "blood exchange" business? Haier Financial Holdings denies the rumor: no connection whatsoever

When it comes to stock trading, just look at reports from the Golden Qilin analyst team—authoritative, professional, timely, and comprehensive. Help you uncover high-potential theme opportunities!

On the morning of March 30, Haier Group (Qingdao) Jinyin Holdings Co., Ltd. (hereinafter referred to as “Haier Jinko Holdings”) issued a statement saying that recently, multiple online platforms have frequently spread rumors that the chairman of the “Yu Meiren Group,” Yu Wenhong, falsely claimed that she/he is associated with Haier Group and its investment enterprises, and fabricated false business claims such as “extracting young people’s blood and blood-replacement therapy.”

The statement clearly states that Yu Wenhong and her/his Yu Meiren have no affiliation with Haier, that he/she is not an employee of Haier, and that Haier Group and its subsidiaries have never carried out any cooperation with Yu Meiren and have never authorized her/him to publicize externally under the name of Haier. In addition, any “blood-replacement” related businesses are not related to Haier. Haier Group and its subsidiaries conduct business in strict accordance with the law and relevant regulations and have never engaged in or participated in rumored businesses such as “extraction of blood microvesicles and blood-replacement therapy.”

The statement emphasizes that it will resolutely safeguard its rights and pursue legal responsibility. For units and individuals who continuously misuse the Haier brand, engage in false advertising, maliciously defame others, or spread rumors, evidence has already been secured, and their responsibilities will be strictly pursued through legal channels, with absolutely no leniency.

According to official information released by Haier Jinko Holdings, Ying Kang Life is Haier Group’s large health ecosystem brand. Tianyancha APP shows that the company is a financial investment platform under Haier Group, established in 2014, with registered capital of RMB 11.7 billion, and the legal representative is Zhang Lei. Its main businesses include financial leasing, financial factoring, and industrial investment, among others. Shareholder information shows that the company is 100% held by Qingdao Haironghui Holdings Co., Ltd.; and the latter is controlled by Haier Group, with a shareholding ratio of 51.2%.

At present, Haier Jinko Holdings has transformed into an industrial investment platform. In December 2021, the company completed a name change, from Haier Group (Qingdao) Financial Holdings Co., Ltd. to Haier Group (Qingdao) Jinyin Holdings Co., Ltd. Before the name change, its main business was investing in financial and financial service institutions, and asset management; after the name change, its main business changed to investing activities using its own funds, focusing on integration and synergy between industry and finance. It has subsidiaries such as Haier Financial Leasing. In December last year, Haier Financial Leasing increased its capital by RMB 500 million, raising registered capital from RMB 4.29 billion to RMB 4.79 billion, an increase of approximately 11.66%.

According to the annual report released by Haier Jinko Holdings, in 2024 the company achieved operating revenue of RMB 12.618 billion, up 55.78% year over year; net profit of RMB 2.708 billion, up 0.97%.

Haier Jinko Holdings has previously drawn significant attention due to its investment in CITIC Securities (601995.SH). Since 2022, Haier Jinko Holdings has repeatedly reduced its holdings of CITIC Securities; in only 2024, the amount reduced already reached RMB 6.850 billion. In November 2024, CITIC Securities announced that Haier Jinko Holdings’ plan to reduce its holdings in the company had been fully implemented, with a total reduction amount of RMB 3.833 billion. After completion of the reduction, Haier Jinko Holdings no longer held any A-share shares of CITIC Securities. Taking this reduction into account, since 2022 Haier Jinko Holdings has carried out five reductions of its holdings of CITIC Securities in total, totaling cash proceeds of RMB 14.269 billion. According to Haier Jinko Holdings’ financial report, its investment cost in CITIC Securities was RMB 5.458 billion.

Meanwhile, while reducing its holdings of CITIC Securities, the subsidiary of Haier Jinko Holdings, Haiyingkang (Qingdao) Medical Technology Co., Ltd., also successfully completed the acquisition of a 20% equity stake in Shanghai RAAS (002252.SZ), becoming the first largest shareholder of Shanghai RAAS. Shanghai RAAS’ 2025 annual report shows that Haiyingkang (Qingdao) holds 23.31% of the equity of Shanghai RAAS.

In addition, according to two administrative penalty decisions released on May 2025 by the official website of the People’s Bank of China Chongqing Branch, the investment enterprise under Haier Jinko Holdings, Chongqing Haier Small Loan Co., Ltd. (hereinafter referred to as “Chongqing Haier Small Loan”), was fined RMB 480,000 for violating relevant management regulations related to the collection, provision, and querying of credit information.

According to the equity penetration information in the Tianyancha APP, Chongqing Haier Small Loan is a wholly owned subsidiary of Chongqing Haier Yunlian Technology Co., Ltd.; and Chongqing Haier Yunlian Technology Co., Ltd. is a wholly owned subsidiary of Haier Jinko Holdings.

For abundant information and precise analysis, it’s all in the Sina Finance APP